Skip to main content

Corient Private Wealth LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1948780 MIAMI, FL

Position in HALO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$12,323,906
-$907,274 QoQ
Shares Held
190,684
-3.0% QoQ
Ownership
0.161%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
13 quarters on record
Voting authority Sole 54.544357652095.ToString("F0")% Shared 0.ToString("F0")% None 45.455642347905005.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Corient Private Wealth LLC holds $187,873,632 across 105 Biotechnology names. HALO ranks #4 (6.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 HALO
Halozyme Therapeutics, Inc.
This page
190,684 $12,323,906

All Filings in HALO

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $12,323,906 190,684
2025-12-31 $13,231,180 196,600
2025-09-30 $871,351 11,881
2025-06-30 $417,720 8,030
2025-03-31 $625,273 9,799
2024-12-31 $276,293 5,779
2024-09-30 $1,158,708 20,243
2024-06-30 $1,447,910 27,653
2024-03-31 $895,651 22,017
2023-12-31 $808,721 21,881
2023-09-30 $713,385 18,675
2023-06-30 $598,762 16,600
2022-12-31 $283,133 4,976